STERIS

Active

Public limited companyfounded 199036 yrs activeTerhulpsesteenweg 177, 1170 Watermaal-Bosvoorde, BelgiumKBO/BCE: BE 0440.556.578

Summary

STERIS has been active since 1990 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €504,676. Equity is shrinking by ~23% per year across the filed fiscal years. Its solvency ranks better than 14% of 5048 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Risk analysis Watch Report Compare

STERISActiveChecked score 58/100

Risk analysis Report Compare

Checked score

Score 2025

58 / 100

Fair

Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability62▲+4

Solvency36▲+3

Growth64▼-3

Track record100

Bankruptcy probability, 12 months

0.6% Low

0%0.5%1.5%4%10%≥ 25%

Credit up to €85,000 at 30 days acceptable

Liquidity tight (current ratio 1.17 against 1.12 in 2024; short-term debt: 85.6% and cash: 32.1% of total assets), and 88.5% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 46

Relative position

BE, all sectors

reference

Wholesale trade (NACE 46)

about 21% more bankruptcies

← fewer bankruptcies more bankruptcies →

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

11.5%

Return on assets

3.8%

Age of the figures

18 mo

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 5048 sector peers (2025).

NBB · sector comparison

Position among 5048 sector peers

Solvency

better than 14%

← weakest strongest →

Filed after the deadline

The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 26-11-2025, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 10 filings

Deviation from the deadline

2025

26 d late

2024

8 d late

2023

4 d early

2022

3 d late

2021

24 d early

2020

4 d early

2019

1 d early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 1 day after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 3 November (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Position in the running window

31-03-2026 close30-09-2026 today31-10-2026 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

History

On 10 April 1990, STERIS was incorporated.¹ The registered office moved to Berchem in 2011, to Antwerpen in 2013 and to Watermaal-Bosvoorde in 2023.²³⁴ Of the 3 current board members, John Patrick Ubbing has served longest, since 2022.⁵ Revenue went from EUR 6.8 million in 2019 to EUR 14 million in 2025 and headcount from 7.5 to 16.2 full-time equivalents.⁶

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover

€14.1m▼ 1.2%

2024 · €14.2m

EBIT margin

5.0%▲ 2.3pp

2024 · 2.8%

Net result

€504,676▲ 90.9%

2024 · €264,328

Working capital

€1.9m▲ 45.2%

2024 · €1.3m

Trend over the years

Chart Table

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before

favourable unfavourable

Line20212022202320242025

Turnover€8.3m▲ 13.7%€9.2m▲ 10.9%€10.9m▲ 18.0%€14.2m▲ 30.7%€14.1m▼ 1.2%

Operating result€382,426▲ 7.5%€343,907▼ 10.1%€895,594▲ 160%€395,514▼ 55.8%€709,365▲ 79.4%

Net result€268,761▼ 3.2%€250,316▼ 6.9%€637,621▲ 155%€264,328▼ 58.5%€504,676▲ 90.9%

EBIT margin4.6%▼ 0.3pp3.7%▼ 0.9pp8.2%▲ 4.5pp2.8%▼ 5.4pp5.0%▲ 2.3pp

Equity€5.9m▲ 4.8%€1.6m▼ 72.5%€2.2m▲ 39.6%€1.0m▼ 55.0%€1.5m▲ 49.9%

Total assets€10.8m▲ 0.2%€7.3m▼ 31.8%€8.4m▲ 14.3%€12.1m▲ 43.8%€13.2m▲ 9.3%

Debt€4.9m▼ 4.8%€5.7m▲ 16.6%€6.2m▲ 7.2%€11.1m▲ 79.9%€11.7m▲ 5.6%

Working capital€5.9m▲ 5.1%€1.7m▼ 71.5%€2.3m▲ 35.2%€1.3m▼ 43.1%€1.9m▲ 45.2%

Solvency54.4%▲ 2.4pp21.9%▼ 32.5pp26.7%▲ 4.8pp8.4%▼ 18.4pp11.5%▲ 3.1pp

Current ratio2.22▲ 0.121.30▼ 0.921.37▲ 0.081.12▼ 0.251.17▲ 0.05

Return on assets (ROA)2.5%▼ 0.1pp3.4%▲ 0.9pp7.6%▲ 4.2pp2.2%▼ 5.4pp3.8%▲ 1.6pp

Staff (FTE)7.3▲ 2.8%8.1▲ 11.0%9.2▲ 13.6%16▲ 73.9%16.2▲ 1.3%

above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.

Result per fiscal year

Operating resultNet result

The operating result recovers in 2025; 2025 is 79% above 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €13.2m

99.9%

Fixed assets €18,039 ▼ 32.4%

Current assets €13.2m ▲ 9.4%

Equity and liabilities €13.2m

11%

88.5%

Equity €1.5m ▲ 49.9%

Debt €11.7m ▲ 5.6%

Debt's share of the balance-sheet total falls from 91.6% to 88.5%. Equity and debt are higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€718,000▲

2024 · €406,194

Cash flow

€513,311▲

2024 · €275,008

Quick ratio

1.16▲

2024 · 1.12

Debt to equity

7.71▼

2024 · 10.95

ROE

33.3%▲

2024 · 26.2%

Interest coverage

216.15▲

2024 · 33.98

Debt ≤ 1 year

€11.3m▲

2024 · €10.8m

Income taxes

€202,474▲

2024 · €119,234

Staff costs

€2.3m▲

2024 · €1.8m

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 4,681 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 97% are still going.

Small
20 years or older
solvency 10 to 30%
a profit under 5% of the balance sheet

1.1% went bankrupt

2.0% stopped otherwise

97% still going

For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	1.0%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 4,681 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Filed annual accounts As filed with the NBB · 2025 against 2024 · 68 lines

Balance sheet Code20242025

Assets

Total assets20/58€12.1m€13.2m▲

Fixed assets21/28€26,675€18,039▼

Tangible fixed assets22/27€21,575€12,939▼

Plant, machinery and equipment23€21,575€11,675▼

Furniture and vehicles24-€1,265

Financial fixed assets28€5,100€5,100=

Other financial fixed assets284/8€5,100€5,100=

Amounts receivable and cash guarantees285/8€5,100€5,100=

Current assets29/58€12.1m€13.2m▲

Stocks and contracts in progress3€52,812€18,438▼

Stocks30/36€52,812€18,438▼

Goods purchased for resale34€52,812€18,438▼

Amounts receivable within one year40/41€10.0m€8.9m▼

Trade receivables40€9.7m€8.9m▼

Other amounts receivable41€254,466€2,900▼

Cash at bank and in hand54/58€2.0m€4.2m▲

Deferred charges and accrued income490/1€8,544-

Equity and liabilities

Total equity and liabilities10/49€12.1m€13.2m▲

Equity10/15€1.0m€1.5m▲

Contributions10/11€303,670€303,670=

Capital10€303,670€303,670=

Issued capital100€303,670€303,670=

Reserves13€30,367€30,367=

Non-distributable reserves130/1€30,367€30,367=

Legal reserve130€30,367€30,367=

Profit (loss) carried forward14€676,595€1.2m▲

Amounts payable17/49€11.1m€11.7m▲

Amounts payable within one year42/48€10.8m€11.3m▲

Trade debts44€5.4m€6.1m▲

Suppliers440/4€5.4m€6.1m▲

Advances received on contracts in progress46€4.4m€4.5m▲

Taxes, remuneration and social security45€950,282€723,258▼

Taxes450/3€478,767€290,085▼

Remuneration and social security454/9€471,514€433,173▼

Other amounts payable47/48€2,059€2,059=

Accrued charges and deferred income492/3€311,136€383,675▲

Income statement Code20242025

Operating income70/76A€15.5m€16.1m▲

Turnover70€14.2m€14.1m▼

Other operating income74€1.3m€2.0m▲

Non-recurring operating income76A€0€957▲

Operating charges60/66A€15.1m€15.4m▲

Goods for resale, raw materials and consumables60€12.4m€12.5m▲

Purchases600/8€12.4m€12.0m▼

Change in stocks: decrease (increase)609-€1,417€556,733▲

Services and other goods61€706,693€949,802▲

Remuneration, social security and pensions62€1.8m€2.3m▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10,680€8,635▼

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€228,006-€483,977▼

Other operating charges640/8€510€118▼

Non-recurring operating charges66A€17,947€95,447▲

Operating profit (loss)9901€395,514€709,365▲

Financial income75/76B-€1,107

Recurring financial income75-€1,107

Other financial income752/9-€1,107

Financial charges65/66B€11,952€3,322▼

Recurring financial charges65€11,952€3,322▼

Other financial charges652/9€11,952€3,322▼

Profit (loss) for the period before taxes9903€383,562€707,150▲

Income taxes67/77€119,234€202,474▲

Taxes670/3€119,234€209,781▲

Tax adjustments and reversals of tax provisions77-€7,306

Profit (loss) for the period9904€264,328€504,676▲

Profit (loss) for the period to be appropriated9905€264,328€504,676▲

Appropriation of the result

Profit (loss) to be appropriated9906€2.2m€1.2m▼

Profit (loss) brought forward from the previous period14P€1.9m€676,595▼

Profit to be distributed694/7€1.5m-

Return on contributions (dividend)694€1.5m-

Social balance

Average headcount (FTE)908716.016.2▲

The notes to these accounts (38 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line	2021	2022	2023	2024	2025	Change
Operating income70/76A	€8.3m	€9.2m	€11.3m	€15.5m	€16.1m	▲ 3.4%
Turnover70	€8.3m	€9.2m	€10.9m	€14.2m	€14.1m	▼ 1.2%
Other operating income74	-	-	€422,160	€1.3m	€2.0m	▲ 52.9%
Non-recurring operating income76A	-	-	€7,377	€0	€957	▲ 683,514%
Operating charges60/66A	€7.9m	€8.9m	€10.4m	€15.1m	€15.4m	▲ 1.4%
Goods for resale, raw materials and consumables60	€5.9m	€6.6m	€7.9m	€12.4m	€12.5m	▲ 1.0%
Purchases600/8	-	€6.4m	€8.2m	€12.4m	€12.0m	▼ 3.5%
Change in stocks: decrease (increase)609	-€33,880	€131,143	-€249,224	-€1,417	€556,733	▲ 39,382%
Services and other goods61	€1.1m	€1.3m	€1.3m	€706,693	€949,802	▲ 34.4%
Remuneration, social security and pensions62	€877,128	€1.0m	€1.2m	€1.8m	€2.3m	▲ 26.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€1,121	€3,556	€3,556	€10,680	€8,635	▼ 19.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4	€39,524	€17,169	-	€228,006	-€483,977	▼ 312%
Other operating charges640/8	€200	€1,792	€285	€510	€118	▼ 76.9%
Non-recurring operating charges66A	-	-	€2,089	€17,947	€95,447	▲ 432%
Operating profit (loss)9901	€382,426	€343,907	€895,594	€395,514	€709,365	▲ 79.4%
Financial income75/76B	-	€30,820	-	-	€1,107	-
Recurring financial income75	€50,503	€30,820	-	-	€1,107	-
Income from current assets751	€50,503	€30,820	-	-	-	-
Other financial income752/9	-	-	-	-	€1,107	-
Financial charges65/66B	€62,787	€16,586	€16,928	€11,952	€3,322	▼ 72.2%
Recurring financial charges65	€62,787	€16,586	€16,928	€11,952	€3,322	▼ 72.2%
Other financial charges652/9	€62,787	€16,586	€16,928	€11,952	€3,322	▼ 72.2%
Profit (loss) for the period before taxes9903	€370,142	€358,141	€878,666	€383,562	€707,150	▲ 84.4%
Income taxes67/77	€101,381	€107,825	€241,045	€119,234	€202,474	▲ 69.8%
Taxes670/3	€104,251	€107,825	€241,045	€119,234	€209,781	▲ 75.9%
Tax adjustments and reversals of tax provisions77	€2,870	-	-	-	€7,306	-
Profit (loss) for the period9904	€268,761	€250,316	€637,621	€264,328	€504,676	▲ 90.9%
Profit (loss) for the period to be appropriated9905	€268,761	€250,316	€637,621	€264,328	€504,676	▲ 90.9%

Line	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€10.8m	€7.3m	€8.4m	€12.1m	€13.2m	▲ 9.3%
Fixed assets21/28	€29,759	€25,686	€37,724	€26,675	€18,039	▼ 32.4%
Tangible fixed assets22/27	€23,774	€20,217	€32,255	€21,575	€12,939	▼ 40.0%
Plant, machinery and equipment23	€23,774	€20,217	€21,509	€21,575	€11,675	▼ 45.9%
Furniture and vehicles24	-	-	€10,745	-	€1,265	-
Financial fixed assets28	€5,985	€5,469	€5,469	€5,100	€5,100	=
Other financial fixed assets284/8	€5,985	€5,469	€5,469	€5,100	€5,100	=
Amounts receivable and cash guarantees285/8	€5,985	€5,469	€5,469	€5,100	€5,100	=
Current assets29/58	€10.7m	€7.3m	€8.4m	€12.1m	€13.2m	▲ 9.4%
Stocks and contracts in progress3	€178,489	€30,177	€279,401	€52,812	€18,438	▼ 65.1%
Stocks30/36	€178,489	€30,177	€279,401	€52,812	€18,438	▼ 65.1%
Goods purchased for resale34	€178,489	€30,177	€279,401	€52,812	€18,438	▼ 65.1%
Amounts receivable within one year40/41	€8.4m	€4.4m	€4.8m	€10.0m	€8.9m	▼ 10.6%
Trade receivables40	€3.9m	€4.4m	€4.8m	€9.7m	€8.9m	▼ 8.3%
Other amounts receivable41	€4.6m	€3,700	€16,148	€254,466	€2,900	▼ 98.9%
Cash at bank and in hand54/58	€2.1m	€2.9m	€3.3m	€2.0m	€4.2m	▲ 111%
Deferred charges and accrued income490/1	-	-	€5,931	€8,544	-	-
Equity and liabilities
Total equity and liabilities10/49	€10.8m	€7.3m	€8.4m	€12.1m	€13.2m	▲ 9.3%
Equity10/15	€5.9m	€1.6m	€2.2m	€1.0m	€1.5m	▲ 49.9%
Contributions10/11	€303,670	€303,670	€303,670	€303,670	€303,670	=
Capital10	€303,670	€303,670	€303,670	€303,670	€303,670	=
Issued capital100	€303,670	€303,670	€303,670	€303,670	€303,670	=
Reserves13	€30,367	€30,367	€30,367	€30,367	€30,367	=
Non-distributable reserves130/1	€30,367	€30,367	€30,367	€30,367	€30,367	=
Legal reserve130	€30,367	€30,367	€30,367	€30,367	€30,367	=
Profit (loss) carried forward14	€5.5m	€1.3m	€1.9m	€676,595	€1.2m	▲ 74.6%
Amounts payable17/49	€4.9m	€5.7m	€6.2m	€11.1m	€11.7m	▲ 5.6%
Amounts payable within one year42/48	€4.8m	€5.6m	€6.1m	€10.8m	€11.3m	▲ 5.1%
Trade debts44	€2.3m	€2.8m	€3.4m	€5.4m	€6.1m	▲ 12.1%
Suppliers440/4	€2.3m	€2.8m	€3.4m	€5.4m	€6.1m	▲ 12.1%
Advances received on contracts in progress46	€2.1m	€2.3m	€2.1m	€4.4m	€4.5m	▲ 2.6%
Taxes, remuneration and social security45	€451,579	€547,731	€576,781	€950,282	€723,258	▼ 23.9%
Taxes450/3	€172,096	€225,420	€20,043	€478,767	€290,085	▼ 39.4%
Remuneration and social security454/9	€279,483	€322,311	€556,739	€471,514	€433,173	▼ 8.1%
Other amounts payable47/48	-	-	-	€2,059	€2,059	=
Accrued charges and deferred income492/3	€79,726	€99,802	€66,403	€311,136	€383,675	▲ 23.3%

Line	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	€268,761	€250,316	€637,621	€264,328	€504,676	▲ 90.9%
+ Depreciation and write-downs630	€1,121	€3,556	€3,556	€10,680	€8,635	▼ 19.1%
Operating cash flow (approximation)	€269,882	€253,872	€641,178	€275,008	€513,311	▲ 86.7%
Investment in fixed assets (approximation)	-	€516	-€15,594	€369	€0	▼ 100%
Change in cash	-	€737,910	€366,036	-€1.2m	€2.2m	▲ 280%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

All 40Financial 3Gazette 27Filings 10

Next filing, fiscal year 2026, expected by 31-10-2026

2026

09-02

State Gazette act Resignation: Michael Tokich (director)

Appointment: Karen Burton (director) · Mandate compensation7 facts ▸

Written resolution, 08-12-2025
Director resignation, Michael Tokich (director)
Director appointment, Karen Burton (director)
Mandate compensation, Karen Burton
Board composition, Karen Burton (director)
Board composition, John Patrick Ubbing (director)
Board composition, Allan Rowley (director)

2025

26-11

NBB filing Annual accounts filed

fiscal year 2025 · full schema · 26 days late

05-11

State Gazette act Miscellaneous

Power of attorney2 facts ▸

Board meeting, 25-07-2025
Power of attorney, Solene Dumacq

24-04

State Gazette act Resignations & appointments

Power of attorney3 facts ▸

Board meeting, 11-02-2025
Power of attorney, Yoann Rouges
Power of attorney, Aurélie Laborde

2024

08-11

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 8 days late

31-10

State Gazette act Resignation: Ronald Snyder (director)

Appointment: Allan Rowley (director) · Reappointment: Michael Tokich (director) · Mandate compensation12 facts ▸

General meeting, 09-09-2024
Director resignation, Ronald Snyder (director)
Director appointment, Allan Rowley (director)
Mandate compensation, Allan Rowley
Board composition, Michael Tokich (director)
Board composition, John Patrick Ubbing (director)
Board composition, Allan Rowley (director)
Board meeting, 09-09-2024
Power of attorney, Ronald Snyder
General meeting, 26-09-2024
Director reappointment, Michael Tokich (director)
Mandate compensation, Michael Tokich

27-05

State Gazette act Appointments: Anne-Gaëlle Le Bail (représentant légal) and Gjanaj Suleman (représentant légal)

3 facts ▸

Board meeting, 11-03-2024
Director appointment, Anne-Gaëlle Le Bail (représentant légal)
Director appointment, Gjanaj Suleman (représentant légal)

2023

20-12

State Gazette act Reappointment: EY Bedrijfsrevisoren BV (statutory auditor)

Permanent representative: Filip Simpelaere · Power of attorney7 facts ▸

General meeting, 28-09-2023
General meeting, 30-11-2023
Auditor reappointment, EY Bedrijfsrevisoren BV (statutory auditor)
Permanent representative, Filip Simpelaere
Board meeting, 06-11-2023
Power of attorney, Julia Madsen
Power of attorney, Hervé Brayard

27-10

NBB filing Annual accounts filed

fiscal year 2023 · full schema

06-10

State Gazette act Resignations & appointments

Power of attorney2 facts ▸

Board meeting
Power of attorney, Yoann Rouges

31-03

Financial Highest result since 2019net €637,621 ▲155%

Operating result €895,594, net result €637,621, both a record.

31-03

Financial Equity above €2mEq €2.2m ▲39.6%

5 profitable years in a row build equity to €2.2m.

Show earlier events

11-01

State Gazette act Resignation: Julia Kipnis (director)

Appointment: John Patrick Ubbing (director) · Mandate compensation7 facts ▸

General meeting, 27-10-2022
Director resignation, Julia Kipnis (director)
Director appointment, John Patrick Ubbing (director)
Mandate compensation, John Patrick Ubbing
Board composition, Michael Tokich (director)
Board composition, Ronald Snyder (director)
Board composition, John Patrick Ubbing (director)

10-01

State Gazette act Statutes amendment

Capital4 facts ▸

General meeting, 23-12-2022
Statutes amendment
Statutes amendment
Capital, €303.669,56

04-01

State Gazette act Registered office

Registered-office move · Statutes amendment3 facts ▸

General meeting, 23-12-2022
Registered-office move, 1170 Watermaal-Bosvoorde, Terhulpensesteenweg 177, bus 11
Statutes amendment

2022

03-11

NBB filing Annual accounts filed

fiscal year 2022 · full schema · 3 days late

31-03

Financial Weakest financial yearnet €250,316 ▼6.9%

Net result drops to €250,316, the lowest in the series; recovery starts the following year.

2021

07-10

NBB filing Annual accounts filed

fiscal year 2021 · full schema

2020

26-11

State Gazette act Reappointment: EY Bedrijfsrevisoren (statutory auditor)

Permanent representative: Eef Naessens3 facts ▸

General meeting, 30-09-2020
Auditor reappointment, EY Bedrijfsrevisoren
Permanent representative, Eef Naessens

27-10

NBB filing Annual accounts filed

fiscal year 2020 · full schema

2019

30-10

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2018

07-11

State Gazette act Reappointments: Michael Tokich (director) and Ronald Snyder (director)

Mandate compensation8 facts ▸

General meeting, 28-09-2018
Director reappointment, Michael Tokich (director)
Director reappointment, Ronald Snyder (director)
Mandate compensation, Michael Tokich
Mandate compensation, Ronald Snyder
Board composition, Michael Tokich (director)
Board composition, Ronald Snyder (director)
Board composition, Julia Kipnis (director)

24-10

NBB filing Annual accounts filed

fiscal year 2018 · full schema

17-05

NBB filing Annual accounts filed

fiscal year 2017 · full schema · 198 days late

2017

25-10

State Gazette act Reappointment: Ernst & Young Bedrijfsrevisoren (statutory auditor)

Permanent representative: Eef Naessens3 facts ▸

General meeting, 30-09-2017
Auditor reappointment, Ernst & Young Bedrijfsrevisoren (statutory auditor)
Permanent representative, Eef Naessens

2016

24-11

State Gazette act Resignation: Dennis Patton (director)

Appointment: Julia Kipnis (director) · Mandate compensation5 facts ▸

Board meeting, 20-10-2016
Director resignation, Dennis Patton (director)
General meeting, 20-10-2016
Director appointment, Julia Kipnis (director)
Mandate compensation, Julia Kipnis

14-11

NBB filing Annual accounts filed

fiscal year 2016 · full schema · 14 days late

2015

08-12

State Gazette act Registered office

Registered-office move2 facts ▸

Board meeting, 24-11-2015
Registered-office move, De Keyserlei 58-60, bus 19, 2018 Antwerpen

2014

23-10

State Gazette act Reappointment: Ernst & Young Bedrijfsrevisoren bcvba (statutory auditor)

2 facts ▸

General meeting, 30-09-2014
Auditor reappointment, Ernst & Young Bedrijfsrevisoren bcvba

05-06

State Gazette act Resignations & appointments

Power of attorney · Ratification4 facts ▸

Board meeting, 30-04-2014
Power of attorney, George Roszkowski
Power of attorney, Dorian Howells
Ratification, alle handelingen gesteld door de heren Roszkowski en Howells vóór deze resolutie binnen de perken van de hierboven beschreven bevoegdheden hierbij gedekt en ger…

2013

06-11

State Gazette act Reappointments: Michael Tokich (director) and Dennis Patton (director)

Mandate compensation5 facts ▸

General meeting, 25-09-2013
Director reappointment, Michael Tokich (director)
Director reappointment, Dennis Patton (director)
Mandate compensation, Michael Tokich
Mandate compensation, Dennis Patton

29-07

State Gazette act Resignation: Mark McGinley (director)

Appointment: Ronald E. Snyder (director) · Mandate compensation4 facts ▸

General meeting, 17-06-2013
Director resignation, Mark McGinley (director)
Director appointment, Ronald E. Snyder (director)
Mandate compensation, Ronald E. Snyder

23-01

State Gazette act Registered office · Resignations & appointments

Registered-office move2 facts ▸

Board meeting, 21-12-2012
Registered-office move, 2018 Antwerpen, Kievitplein 20, gebouw C/12

2012

31-08

State Gazette act Reappointment: Ernst & Young Bedrijfsrevisoren bcvba (statutory auditor)

2 facts ▸

General meeting, 30-09-2011
Auditor reappointment, Ernst & Young Bedrijfsrevisoren bcvba

2011

28-03

State Gazette act Registered office · Statutes amendment

Capital · Registered-office move4 facts ▸

General meeting, 04-03-2011
Statutes amendment
Capital, €303.669,56
Registered-office move, 2600 Berchem, Uitbreidingstraat 80

2009

13-02

State Gazette act Appointment: Eric Van Hoof (permanent representative)

2 facts ▸

General meeting, 15-01-2009
Director appointment, Eric Van Hoof (permanent representative)

2008

10-11

State Gazette act Resignations & appointments

Power of attorney5 facts ▸

Board meeting, 20-10-2008
Power of attorney, Johan Van Den Bergh
Power of attorney, Mandy Gomm
Power of attorney, Daniel Bedoure
Power of attorney, George Roszkowski

13-10

State Gazette act Reappointment: Ernst & Young Réviseurs d'Entreprises SCC (statutory auditor)

2 facts ▸

General meeting, 25-09-2008
Auditor reappointment, Ernst & Young Réviseurs d'Entreprises SCC

13-10

State Gazette act Reappointments: Michael Tokich, Mark McGinley and Dennis Patton

Mandate compensation · Power of attorney13 facts ▸

General meeting, 06-09-2007
Director reappointment, Michael Tokich (director)
Director reappointment, Mark McGinley (director)
Director reappointment, Dennis Patton (director)
Mandate compensation, Michael Tokich
Mandate compensation, Mark McGinley
Mandate compensation, Dennis Patton
Power of attorney, Danielle Machiroux
Power of attorney, Olivier Rousselle
Power of attorney, Danielle Machiroux
Power of attorney, Olivier Rousselle
Power of attorney, Danielle Machiroux
+1 further facts in this act

2005

03-10

State Gazette act Reappointment: Ernst & Young Réviseurs d'Entreprises SCC (statutory auditor)

Mandate compensation3 facts ▸

General meeting, 01-09-2005
Auditor reappointment, Ernst & Young Réviseurs d'Entreprises SCC (statutory auditor)
Mandate compensation, Ernst & Young Réviseurs d'Entreprises SCC

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.

28 of 28 acts read

Directors · office · real estate

Directors

3 directors, no change since 2025

Board 3

John Patrick Ubbing

Director · since 27-10-2022

Current

Allan Rowley

Director · since 09-09-2024

Current

Karen Burton

Director · since 08-12-2025

Current

1 not recently confirmed

Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.

Ronald E. Snyder

Director · since 17-06-2013

Not recently confirmed

Permanent representatives 2

Anne-Gaëlle Le Bail

Représentant légal · since 11-03-2024

Current

Gjanaj Suleman

Représentant légal · since 11-03-2024

Current

Statutory auditor 1

EY Bedrijfsrevisoren BV

Statutory auditor · since 01-09-2005 · perm. rep.: Filip Simpelaere

Current

Other functions 1

Eric Van Hoof

Permanent representative · since 15-01-2009

Not recently confirmed

Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →

Location & real-estate footprint

Registered office, Watermaal-Bosvoorde · 1 establishment unit since 1990

seat establishment The establishment unit on the map

Ground area

5,127 m²

Building footprint

1,510 m²

Volume, LiDAR

23,163 m³

Parcel 21652E0039/00H003, Brussels · tallest building 36.3 m, ±1 floor. Linked by address, not a title deed.

288 companies at this address See who is registered here

1 establishment unit

STERIS

Terhulpsesteenweg 177, 1170 Watermaal-BosvoordeWholesale of pharmaceutical and medical goods

since 19902.048.091.058

1 parcel

Brussels 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21652E0039/00H003	Brussels	5,127 m²	1 · 1,510 m²	36.3 m · 1 fl.

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Mandate history

13 people since 2005, 8 in office

All 13 In office 8 Ended 5

Board
Permanent representative
Statutory auditor
Other function
not recently confirmed
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
John Patrick Ubbing	Director, from 27-10-2022 to date
Allan Rowley	Director, from 09-09-2024 to date
Karen Burton	Director, from 08-12-2025 to date
Anne-Gaëlle Le Bail	Représentant légal, from 11-03-2024 to date
Gjanaj Suleman	Représentant légal, from 11-03-2024 to date
EY Bedrijfsrevisoren BV	Statutory auditor, from 01-09-2005 to date
Ronald E. Snyder	Director, from 17-06-2013 not ended, last confirmed 29-07-2013
Eric Van Hoof	Permanent representative, from 15-01-2009 not ended, last confirmed 13-02-2009
Michael Tokich	Director, already before 13-10-2008 to 08-12-2025
Ronald Snyder	Director, already before 07-11-2018 to 30-08-2024
Julia Kipnis	Director, from 20-10-2016 to 27-10-2022
Dennis Patton	Director, already before 13-10-2008 to 30-06-2016
Mark McGinley	Director, already before 13-10-2008 to 17-06-2013

Show all 13 people Show the first 12See the board, name and seat on a given date →

Articles of association

Purpose

Le production, la vente et l'entretien d'appareils pour industrie pharmaceutique et biotechnologique, ainsi que la recherche pharmaceutique et autres, et tout ce qui s'y rapporte

Full purpose

Le production, la vente et l'entretien d'appareils pour industrie pharmaceutique et biotechnologique, ainsi que la recherche pharmaceutique et autres, et tout ce qui s'y rapporte.

according to the deed of 10-01-2023

Structure & network

Owners and holdings

2 owners

Owners 2

STERIS HOLDING SANLparent

Sourceown accounts 31-03-2025

99.99%
STERIS DEUTSCHLAND SPRLDE

Sourceown accounts 31-03-2025

0.01%

Holdings 0

The accounts to 31-03-2025 list no holdings, and no other source names one.

According to the annual accounts to 31-03-2025 of STERIS and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

3 current directors

Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Capital and shareholders

Capital over the years

10-01-2023 Capital stated in 2 acts · 303,669.56 EUR · 12,250 shares

Similar companies · same sector, comparable size

F CARE SYSTEMS

BE 0458.708.347

Antwerpen · Eq €1,500,072

THE BINDING SITE BENELUX

BE 0823.233.060

Merelbeke-Melle · Eq €1,530,723

INTERSCIENCE BELGIUM

BE 0434.341.254

Ottignies-Louvain-la-Neuve · Eq €1,536,618

Kampenhout · Eq €1,486,363

Of 1,903 companies in sector 46460 we hold annual accounts for 1,126. 736 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPublic limited company

Founded10-04-1990

Fiscal year end31-03

Activities, NACEBEL 2025

46460Wholesale of pharmaceutical and medical goods

Contact

E-mail rh_francebelgique@steris.comWatermaal-Bosvoorde

E-invoicing

Reachable via Peppol

Peppol ID 0208:0440556578

Registered 15-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Scores and ratios are computed by Checked and are not a credit decision.